PropertyValue
?:abstract
  • Severe coronavirus disease 2019 (COVID-19) causes a hyperactivation of immune cells, resulting in lung inflammation. Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant breast cancer cells such as neutrophil extracellular traps (NETs). The presence of NETs and of a pro-inflammatory microenvironment may therefore promote breast cancer reactivation, increasing the risk of pulmonary metastasis. Further studies will be required to confirm the link between COVID-19 and cancer recurrence. However, an increased awareness on the potential risks for breast cancer patients with COVID-19 may lead to improved treatment strategies to prevent metastatic relapse.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1186/s13058-020-01360-0
?:journal
  • Breast_Cancer_Res
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/01bbb4301fc0976a3a4d8fa602a1f686863568ef.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7598231.xml.json
?:pmcid
?:pmid
?:pmid
  • 33126915.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19: a potential driver of immune-mediated breast cancer recurrence?
?:type
?:year
  • 2020-10-30

Metadata

Anon_0  
expand all